BioAge Labs, Inc. (BIOA)
Nasdaq: BIOA · Pharmaceutical Preparations · Emeryville, CA · filing with the SEC since 2024
Who runs BioAge Labs, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Fortney Kristen
Chief Executive Officer. First filing Sep 2024, latest Feb 19, 2026, 1 filing in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
11 people on the record since 2024
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Barton Shane | Principal Accounting Officer | Sep 2024 | Jul 1, 2026 | 2 · $1.6M |
| Goldstein Dov A Md | Chief Financial Officer | Sep 2024 | Apr 24, 2026 | 4 · $500,000 |
| Rubin Paul D | Chief Medical Officer | Sep 2024 | Apr 3, 2026 | 6 · $1.5M |
| Fortney Kristen | Chief Executive Officer | Sep 2024 | Feb 19, 2026 | 1 · $4.2M |
| Morgen Eric | Chief Operating Officer | Sep 2024 | Feb 19, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Davidson Michael H. | director | Sep 2024 | Jun 12, 2026 | none |
| Enright Patrick G | director | Sep 2024 | Jun 12, 2026 | none |
| Garnier Jean Pierre | director | Sep 2024 | Jun 12, 2026 | none |
| Healy James | director | Sep 2024 | Jun 12, 2026 | none |
| Hemrajani Rekha | director | Sep 2024 | Jun 12, 2026 | none |
| Pande Vijay Satyanand | director | Sep 2024 | Jun 12, 2026 | none |
Earlier names on the record4, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.